The Patent Finder
DM

Devicor Medical Products, Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

165 patents currently held

2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
80 more records may belong here and await a decision; they are not counted.

The next US patent term in the Devicor Medical Products, Inc. portfolio ends in Nov 2026, and more of its terms end in 2030 (23) than in any other year. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
52
Ending by 2030
Nov 2026
Next term end
119
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
MRI Biopsy Device US 7,708,751
Cited by 614 later US patents, top 1% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028.
Ends Jan 2028 · High confidence
Also notable
Biopsy Device with Vacuum Assisted Bleeding Control US 7,918,804
Cited by 135 later US patents, top 5% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Ends Feb 2029 · High confidence
Also notable
Tetherless Biopsy Device with Reusable Portion US 8,206,316
Cited by 202 later US patents, top 5% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Ends Jun 2030 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 11, 2026
    The maintenance fee for Graphical User Interface for Biopsy Device (US 10,314,563) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
  • 4 fees due Jan 2 to 23, 2027 · next Jan 2
  • 2 fees due Feb 4 to 15, 2027 · next Feb 4
  • 3 fees due Mar 3 to 17, 2027 · next Mar 3
  • 2 fees due Apr 22 to 24, 2027 · next Apr 22
  • 2 fees due May 5 to 26, 2027 · next May 5
  • 2 fees due Jun 3 to 30, 2027 · next Jun 3
  • 1 fee due Sep 24, 2027
    The maintenance fee for Control for Biopsy Device (US 10,595,831) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.
  • 3 fees due Oct 5 to 7, 2027 · next Oct 5
  • 2 fees due Nov 12 to 14, 2027 · next Nov 12

Which patents, and when each one lapses · Pro

Recent changes

  • 9 of the patents on this record were granted since Aug 24, 2026
  • 8 terms have ended since Aug 24, 2026

What they patent

The largest of its 119 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US D671,644Ultrasound Biopsy Probe
In force
 · High confidence
In forceHigh confidence
US 7,896,817Biopsy Device with Manually Rotated Sample Barrel
In force
 · High confidence
In forceHigh confidence
US 7,806,835Biopsy Device with Sharps Reduction Feature
In force
 · High confidence
In forceHigh confidence
US 8,968,212Biopsy Device with Motorized Needle Cocking
In force
 · High confidence
In forceHigh confidence
US 9,433,403Icon-Based User Interface on Biopsy System Control Module
In force
 · High confidence
In forceHigh confidence
US 9,486,184Biopsy Sample Storage
In force
 · Low confidence
In forceLow confidence
US D695,404Biopsy Device
In force
 · High confidence
In forceHigh confidence
US 7,806,834Device for Minimally Invasive Internal Tissue Removal
In force
 · High confidence
In forceHigh confidence
US 7,708,751MRI Biopsy Device
In force
 · High confidence
In forceHigh confidence
US D699,347Ultrasound Biopsy Probe
In force
 · High confidence
In forceHigh confidence
10 of 165 patents shown.
Pro members see all 165.
Pro members: see all 165 patents
Also on record, not counted in the 165: 2 patents in force now held by others · 194 patents ended · 34 applications pending · 126 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited